NEW YORK (GenomeWeb) – Roche today reported that its Fiscal Year 2014 revenues for its diagnostics division jumped 3 percent, or 6 percent on a currency-neutral basis, to CHF 10.77 billion ($11.89 billion) from CHF 10.48 billion, driven in part by sales gains in its molecular diagnostics business.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.